{
    "Trade/Device Name(s)": [
        "Wondfo T-Dip\u00ae Multi-Drug Urine Test Panel",
        "Wondfo T-Dip\u00ae Multi-Drug Urine Test Panel Rx"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K202567",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182701"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NFT",
        "NGL",
        "PTH",
        "NFV",
        "NFY",
        "PTG",
        "NGG",
        "LCM",
        "QBF",
        "QAW",
        "NFW"
    ],
    "Summary Letter Date": "September 2, 2020",
    "Summary Letter Received Date": "September 4, 2020",
    "Submission Date": "September 22, 2020",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3150",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3620",
        "21 CFR 862.3610",
        "21 CFR 862.3650",
        "21 CFR 862.3700",
        "21 CFR 862.3910",
        "21 CFR 862.3870"
    ],
    "Regulation Name(s)": [
        "Amphetamine test system",
        "Barbiturate test system",
        "Benzodiazepine test system",
        "Cocaine test system",
        "Methadone test system",
        "Methamphetamine test system",
        "Opiate test system",
        "Propoxyphene test system",
        "Tricyclic antidepressant drugs test system",
        "Cannabinoids test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Buprenorphine",
        "Secobarbital",
        "Oxazepam",
        "Cocaine",
        "2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Methadone",
        "Oxycodone",
        "Phencyclidine",
        "Propoxyphene",
        "Nortriptyline",
        "Cannabinoids"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Wondfo T-Dip\u00ae panel"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Antigen-antibody reaction"
    ],
    "Submission Type(s)": [
        "Panel",
        "Test device",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo T-Dip Multi-Drug Urine Test Panel for qualitative detection of drugs of abuse using lateral flow immunochromatographic assay in human urine",
    "Indications for Use Summary": "Qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbital, Oxazepam, Cocaine, EDDP, Methamphetamine, MDMA, Morphine, Methadone, Oxycodone, Phencyclidine, Propoxyphene, Nortriptyline and Cannabinoids in human urine at specified cutoff concentrations for prescription and over-the-counter use; preliminary positive results should be confirmed by alternative methods such as GC/MS or LC/MS",
    "fda_folder": "Toxicology"
}